Should I buy Parker Hannifin (PH) stock or is it too late?

Parker Hannifin · Industrials · price $1,011
Logo Parker HannifinSee the full Parker Hannifin (PH) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Truist Securities80% of its targets hit on this sector (205 calls tested). It aims for $1,358 (+34 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).

The 7 reliable analysts $1,232+22 %
The 5 other firms $1,060+4.8 %
How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $1,232 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Parker Hannifin

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Wells Fargo95 %+50.4 %22$950 -6%
Baird71 %+41.9 %7$960 -5%
Evercore ISI Group100 %+40.7 %6$1,217 +20%
Jefferies86 %+33.7 %7$1,100 +9%
Argus Research100 %+32.1 %5$900 -11%
Barclays81 %+31.7 %26$1,020 +1%
Morgan Stanley77 %+30.0 %13$1,038 +3%
Truist Securities100 %+29.3 %8$1,358 +34%
In short — Should you invest in Parker Hannifin? Is it too late, still worth it? Analysts are overwhelmingly positive (92% buy, median target $1,218, i.e. +20%), and the most reliable on PH targets even higher. But the valuation is stretched (P/E ~36). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 92% of analysts rate it a buy (Buy consensus, 12 ratings) — a sign of market conviction.
  • Median price target $1,218, i.e. +20% from the current price ($1,011).
  • The most reliable firm on PH, Evercore ISI Group (100% hit rate, 6 scored calls), targets $1,217 (call made on August 11, 2026, maturing on August 11, 2027) (+20%) in its most recent call, and $1,168 (call made on February 23, 2026, maturing on February 23, 2027) (+16%) in the one coming due soonest.
  • 7 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 12 ratings, 1 is neutral.
  • High valuation (P/E ~36): strong growth is already "priced in", leaving little room for error.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on PH

Median target $1,218 (+20%) · 12 ratings · Buy consensus

Strong Buy00%
Buy1192%
Hold18%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Parker Hannifin now?

We won't decide for you. The facts: 92% of analysts rate it a buy, median target $1,218 (+20%), and Evercore ISI Group (most reliable on PH, 100%) targets $1,217. Weigh that against valuation (P/E ~36). This is not personalized advice.

Is it too late to invest in Parker Hannifin?

Not according to analysts: the median target ($1,218) is still +20% above the current price ($1,011) (most reliable on PH: Evercore ISI Group, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Parker Hannifin still worth investing in?

It depends on the gap between the price ($1,011) and its estimated value: analysts target $1,218 on median (+20%), with 92% buys (most reliable on PH: Evercore ISI Group, 100%). Cross-check with their real reliability on PH and the cautions above. Information, not advice.

What's the main risk in buying PH?

The consensus is not unanimous: of 12 ratings, 1 is neutral.

→ Go deeper: the full Parker Hannifin profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)